Company intelligence / Profile preview
Blau Farmacêutica
Cotia, São Paulo, Brazilri.blau.com ↗
- Ownership
- Private
- Employees
- ~4999
- Development stage
- Commercial
01
Overview
Blau Farmacêutica has a broad portfolio of high-complexity biological and synthetic medicines for hospital use across immunology, oncology, hematology, nephrology and infectious disease. The company recently entered into major partnerships to co-develop biosimilars targeting large global markets. Its commercialized products include antivirals like ribavirin; oncology agents such as tamoxifen and pemetrexed; antibiotics including ceftriaxone; anesthetics like propofol; growth hormone somatropin-rhu; among others. Clinical results for specific programs are not publicly detailed but the company’s expansion into biosimilars signals ongoing R&D investment.
- Therapeutic areas
- OncologyImmunologyHematologyOtherNephrologyInfectious Diseases
- Modalities
- Biological drugs (biologics)Synthetic drugsBiosimilarsSmall molecules (antibiotics, anesthetics)Monoclonal antibodiesRecombinant proteins
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Similis Bio – co-development of four major biosimilar programs valued at over $100 million total contract value targeting global markets ($42B+ addressable market worldwide).
Beyond the preview
Go deeper on Blau Farmacêutica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blau Farmacêutica.